NASDAQ:KERN

Akerna Competitors

$3.50
+0.10 (+2.94 %)
(As of 05/11/2021 03:59 PM ET)
Add
Compare
Today's Range
$3.03
$3.54
50-Day Range
$3.64
$5.42
52-Week Range
$2.17
$11.49
Volume20,303 shs
Average Volume2.75 million shs
Market Capitalization$75.59 million
P/E RatioN/A
Dividend YieldN/A
Beta3.04

Competitors

Akerna (NASDAQ:KERN) Vs. GTYH, NH, SJ, BLCT, GSMG, and RENN

Should you be buying KERN stock or one of its competitors? Companies in the industry of "data processing & preparation" are considered alternatives and competitors to Akerna, including GTY Technology (GTYH), NantHealth (NH), Scienjoy (SJ), BlueCity (BLCT), Glory Star New Media Group (GSMG), and Renren (RENN).

GTY Technology (NASDAQ:GTYH) and Akerna (NASDAQ:KERN) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Institutional & Insider Ownership

37.2% of GTY Technology shares are held by institutional investors. Comparatively, 8.8% of Akerna shares are held by institutional investors. 17.2% of GTY Technology shares are held by company insiders. Comparatively, 9.4% of Akerna shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares GTY Technology and Akerna's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GTY Technology$36.44 million7.79$-97,370,000.00N/AN/A
Akerna$12.57 million6.01$-15,530,000.00N/AN/A

Akerna has lower revenue, but higher earnings than GTY Technology.

Profitability

This table compares GTY Technology and Akerna's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GTY Technology-78.50%-0.45%-0.33%
Akerna-146.13%-57.89%-37.26%

Risk & Volatility

GTY Technology has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Akerna has a beta of 3.04, indicating that its share price is 204% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for GTY Technology and Akerna, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GTY Technology00203.00
Akerna00103.00

GTY Technology currently has a consensus price target of $8.00, suggesting a potential upside of 55.34%. Akerna has a consensus price target of $10.50, suggesting a potential upside of 201.72%. Given Akerna's higher possible upside, analysts clearly believe Akerna is more favorable than GTY Technology.

Summary

GTY Technology beats Akerna on 8 of the 12 factors compared between the two stocks.

NantHealth (NASDAQ:NH) and Akerna (NASDAQ:KERN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Insider and Institutional Ownership

5.5% of NantHealth shares are held by institutional investors. Comparatively, 8.8% of Akerna shares are held by institutional investors. 59.6% of NantHealth shares are held by company insiders. Comparatively, 9.4% of Akerna shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares NantHealth and Akerna's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NantHealth$95.96 million2.84$-62,760,000.00($0.57)-4.21
Akerna$12.57 million6.01$-15,530,000.00N/AN/A

Akerna has lower revenue, but higher earnings than NantHealth.

Profitability

This table compares NantHealth and Akerna's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NantHealth-60.94%N/A-32.31%
Akerna-146.13%-57.89%-37.26%

Volatility and Risk

NantHealth has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Comparatively, Akerna has a beta of 3.04, indicating that its stock price is 204% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for NantHealth and Akerna, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NantHealth0000N/A
Akerna00103.00

Akerna has a consensus price target of $10.50, suggesting a potential upside of 201.72%. Given Akerna's higher probable upside, analysts clearly believe Akerna is more favorable than NantHealth.

Summary

Akerna beats NantHealth on 7 of the 12 factors compared between the two stocks.

Scienjoy (NASDAQ:SJ) and Akerna (NASDAQ:KERN) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Insider and Institutional Ownership

0.1% of Scienjoy shares are held by institutional investors. Comparatively, 8.8% of Akerna shares are held by institutional investors. 9.4% of Akerna shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Scienjoy and Akerna, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Scienjoy00103.00
Akerna00103.00

Scienjoy presently has a consensus price target of $56.00, suggesting a potential upside of 625.39%. Akerna has a consensus price target of $10.50, suggesting a potential upside of 201.72%. Given Scienjoy's higher probable upside, equities analysts clearly believe Scienjoy is more favorable than Akerna.

Volatility and Risk

Scienjoy has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Akerna has a beta of 3.04, indicating that its stock price is 204% more volatile than the S&P 500.

Earnings & Valuation

This table compares Scienjoy and Akerna's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ScienjoyN/AN/A$150,000.00N/AN/A
Akerna$12.57 million6.01$-15,530,000.00N/AN/A

Scienjoy has higher earnings, but lower revenue than Akerna.

Profitability

This table compares Scienjoy and Akerna's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ScienjoyN/A76.20%19.76%
Akerna-146.13%-57.89%-37.26%

Summary

Scienjoy beats Akerna on 6 of the 10 factors compared between the two stocks.

Akerna (NASDAQ:KERN) and BlueCity (NASDAQ:BLCT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Valuation and Earnings

This table compares Akerna and BlueCity's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akerna$12.57 million6.01$-15,530,000.00N/AN/A
BlueCity$107.18 million2.24N/AN/AN/A

BlueCity has higher revenue and earnings than Akerna.

Analyst Ratings

This is a breakdown of current ratings for Akerna and BlueCity, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Akerna00103.00
BlueCity00203.00

Akerna currently has a consensus price target of $10.50, indicating a potential upside of 201.72%. BlueCity has a consensus price target of $20.00, indicating a potential upside of 191.55%. Given Akerna's higher probable upside, analysts clearly believe Akerna is more favorable than BlueCity.

Insider and Institutional Ownership

8.8% of Akerna shares are held by institutional investors. Comparatively, 2.0% of BlueCity shares are held by institutional investors. 9.4% of Akerna shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Akerna and BlueCity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Akerna-146.13%-57.89%-37.26%
BlueCityN/AN/AN/A

Summary

BlueCity beats Akerna on 5 of the 9 factors compared between the two stocks.

Glory Star New Media Group (NASDAQ:GSMG) and Akerna (NASDAQ:KERN) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares Glory Star New Media Group and Akerna's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glory Star New Media GroupN/AN/A$3.28 millionN/AN/A
Akerna$12.57 million6.01$-15,530,000.00N/AN/A

Glory Star New Media Group has higher earnings, but lower revenue than Akerna.

Analyst Recommendations

This is a summary of current ratings and target prices for Glory Star New Media Group and Akerna, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Glory Star New Media Group0000N/A
Akerna00103.00

Akerna has a consensus target price of $10.50, indicating a potential upside of 201.72%. Given Akerna's higher probable upside, analysts clearly believe Akerna is more favorable than Glory Star New Media Group.

Insider and Institutional Ownership

0.5% of Glory Star New Media Group shares are owned by institutional investors. Comparatively, 8.8% of Akerna shares are owned by institutional investors. 9.4% of Akerna shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Glory Star New Media Group and Akerna's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Glory Star New Media GroupN/A12.52%2.63%
Akerna-146.13%-57.89%-37.26%

Volatility and Risk

Glory Star New Media Group has a beta of -1.46, suggesting that its stock price is 246% less volatile than the S&P 500. Comparatively, Akerna has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.

Summary

Akerna beats Glory Star New Media Group on 6 of the 10 factors compared between the two stocks.

Renren (NYSE:RENN) and Akerna (NASDAQ:KERN) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares Renren and Akerna's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Renren$349.78 million0.60$-51,090,000.00N/AN/A
Akerna$12.57 million6.01$-15,530,000.00N/AN/A

Akerna has lower revenue, but higher earnings than Renren.

Analyst Recommendations

This is a summary of current ratings and target prices for Renren and Akerna, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Renren0000N/A
Akerna00103.00

Akerna has a consensus target price of $10.50, indicating a potential upside of 201.72%. Given Akerna's higher probable upside, analysts clearly believe Akerna is more favorable than Renren.

Insider and Institutional Ownership

0.6% of Renren shares are owned by institutional investors. Comparatively, 8.8% of Akerna shares are owned by institutional investors. 42.4% of Renren shares are owned by company insiders. Comparatively, 9.4% of Akerna shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Renren has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500. Comparatively, Akerna has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.

Profitability

This table compares Renren and Akerna's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RenrenN/AN/AN/A
Akerna-146.13%-57.89%-37.26%

Summary

Akerna beats Renren on 6 of the 11 factors compared between the two stocks.


Akerna Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
GTY Technology logo
GTYH
GTY Technology
1.5$5.15+1.6%$279.51 million$36.44 million-7.36Upcoming Earnings
News Coverage
Gap Down
NantHealth logo
NH
NantHealth
1.0$2.40+0.0%$272.14 million$95.96 million-5.45Gap Down
SJ
Scienjoy
1.8$7.74+7.2%$254.03 millionN/A8.51Upcoming Earnings
Gap Down
BLCT
BlueCity
1.4$6.74+1.8%$244.57 million$107.18 million0.00Gap Down
GSMG
Glory Star New Media Group
0.0$3.89+0.3%$224.60 millionN/A0.00
Renren logo
RENN
Renren
0.5$9.12+0.3%$209.81 million$349.78 million0.00Gap Down
Innodata logo
INOD
Innodata
0.4$6.26+1.3%$166.72 million$55.86 million-313.00
CooTek (Cayman) logo
CTK
CooTek (Cayman)
1.0$1.86+1.6%$115.70 million$177.88 million-3.21Upcoming Earnings
News Coverage
Gap Up
Fang logo
SFUN
Fang
0.6$11.63+0.4%$104.37 million$219.71 million-2.09
Park City Group logo
PCYG
Park City Group
0.7$5.23+3.1%$99.16 million$20.04 million65.38Upcoming Earnings
News Coverage
Gap Down
WISeKey International logo
WKEY
WISeKey International
1.8$7.21+1.9%$98.33 million$22.65 million-2.25Analyst Report
Gap Down
Greenpro Capital logo
GRNQ
Greenpro Capital
0.8$1.31+9.2%$88.81 million$4.49 million0.00Upcoming Earnings
News Coverage
Gap Down
Phunware logo
PHUN
Phunware
1.3$1.38+10.9%$87.59 million$19.15 million-2.94Upcoming Earnings
Analyst Report
Gap Up
Support.com logo
SPRT
Support.com
0.4$3.00+2.7%$70.46 million$63.33 million100.03News Coverage
Gap Down
MFH
Mercurity Fintech
0.7$6.08+0.8%$50.41 million$1.74 million0.00Gap Down
Net Element logo
NETE
Net Element
0.7$9.81+3.7%$49.22 million$65 million0.00
Sphere 3D logo
ANY
Sphere 3D
0.6$1.47+8.8%$20.04 million$5.58 million-1.08
Marin Software logo
MRIN
Marin Software
0.6$1.48+0.0%$16.23 million$49.04 million-0.85Gap Down
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.